Ekso Bionics Holdings, Inc. (LON:0IFR)
London
· Delayed Price · Currency is GBP · Price in USD 0.4170
0.00 (0.00%)
At close: Apr 16, 2025
Ekso Bionics Holdings Revenue
In the year 2024, Ekso Bionics Holdings had annual revenue of $17.93M USD, down -1.94%. Ekso Bionics Holdings had revenue of $5.09M in the quarter ending December 31, 2024, with 5.01% growth.
Revenue
$17.93M
Revenue Growth
-1.94%
P/S Ratio
0.54
Revenue / Employee
$271.59K
Employees
66
Market Cap
7.72M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17.93M | -354.00K | -1.94% |
| Dec 31, 2023 | 18.28M | 5.37M | 41.57% |
| Dec 31, 2022 | 12.91M | 1.67M | 14.81% |
| Dec 31, 2021 | 11.25M | 2.36M | 26.62% |
| Dec 31, 2020 | 8.88M | -5.04M | -36.18% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| Shell | 227.10B |
| HSBC Holdings | 48.93B |
| Unilever | 50.25B |
| Rio Tinto Group | 42.86B |
| RELX PLC | 9.43B |
| British American Tobacco p.l.c. | 25.87B |
| London Stock Exchange Group | 8.86B |